See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $172B | 0.4x | 10.3x | |
| $26.1B | 7.1x | 29.8x | |
| $23.8B | n/a | n/a | |
| $20.3B | 2.0x | 32.5x | |
| $12.3B | 2.5x | 39.3x | |
| $11.6B | 0.3x | 5.0x | |
| $9.6B | 1.2x | 14.0x | |
| $9.5B | 0.7x | 15.6x | |
| $7.2B | 0.8x | 13.2x | |
| $5.8B | 0.8x | 8.6x | |
| $5.0B | 1.7x | 12.1x | |
| $4.4B | 0.7x | 10.1x | |
| $4.0B | 0.5x | 10.0x | |
| $3.8B | 0.2x | 5.6x | |
| $3.5B | 0.5x | 8.6x | |
| $3.5B | 1.3x | 7.7x | |
| $3.4B | 1.0x | 8.1x | |
| $3.2B | 0.9x | 13.1x | |
| $3.1B | 0.8x | 7.1x | |
| $3.0B | 0.6x | 7.4x | |
| $2.8B | 0.4x | 4.8x | |
| $2.2B | 1.9x | 15.3x | |
| $2.2B | 0.8x | 10.5x | |
| $2.1B | 0.7x | 6.8x | |
| $1.7B | 0.9x | 7.1x | |
| $1.6B | 0.5x | 22.0x | |
| $1.6B | 0.5x | 22.0x | |
| $1.6B | n/a | n/a | |
| $1.5B | 0.4x | 5.6x | |
| $1.5B | 0.5x | 8.7x | |
| $1.3B | n/a | n/a | |
| $1.3B | n/a | n/a | |
| $1.2B | 0.4x | n/a | |
| $1.2B | 1.4x | 4.3x | |
| $1.1B | 1.5x | 18.2x | |
| $1.1B | 0.4x | 9.6x | |
| $1.0B | 0.8x | 10.1x | |
| $977M | n/a | n/a | |
| $968M | 0.2x | 7.8x | |
| $754M | n/a | n/a | |
| $670M | n/a | n/a | |
| $598M | 1.0x | n/a | |
| $538M | 0.5x | 7.7x | |
| $461M | n/a | n/a | |
| $456M | 0.3x | -7.9x | |
| $376M | n/a | n/a | |
| $365M | n/a | n/a | |
| $278M | n/a | n/a | |
| $275M | 0.2x | n/a | |
| $236M | 0.5x | 8.2x | |
| $145M | n/a | n/a | |
| $118M | n/a | n/a | |
| $84.5M | n/a | n/a | |
| $83.8M | n/a | n/a | |
| $56.4M | n/a | n/a | |
| $31.7M | 0.5x | -109.2x | |
| $23.1M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies